These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26207402)

  • 21. Body mass index greater than 35 is associated with severe Clostridium difficile infection.
    Mulki R; Baumann AJ; Alnabelsi T; Sandhu N; Alhamshari Y; Wheeler DS; Perloff S; Katz PO
    Aliment Pharmacol Ther; 2017 Jan; 45(1):75-81. PubMed ID: 27790736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
    Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
    J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in community-acquired Clostridium difficile infection.
    Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
    Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
    Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
    J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations of Clostridium difficile infection in a medical center in Taiwan.
    Lai CC; Lin SH; Tan CK; Liao CH; Huang YT; Hsueh PR
    J Microbiol Immunol Infect; 2014 Dec; 47(6):491-6. PubMed ID: 23978490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation.
    Shah SA; Tsapepas DS; Kubin CJ; Martin ST; Mohan S; Ratner LE; Pereira M; Kapur S; Dadhania D; Walker-McDermott JK
    Transpl Infect Dis; 2013 Oct; 15(5):502-9. PubMed ID: 23890202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma.
    Vanzant EL; Lopez CM; Ozrazgat-Baslanti T; Ungaro R; Davis R; Cuenca AG; Gentile LF; Nacionales DC; Cuenca AL; Bihorac A; Leeuwenburgh C; Lanz J; Baker HV; McKinley B; Moldawer LL; Moore FA; Efron PA
    J Trauma Acute Care Surg; 2014 Jan; 76(1):21-9; discussion 29-30. PubMed ID: 24368353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extraintestinal Clostridium difficile infections: a single-center experience.
    Gupta A; Patel R; Baddour LM; Pardi DS; Khanna S
    Mayo Clin Proc; 2014 Nov; 89(11):1525-36. PubMed ID: 25245597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection.
    Shaughnessy MK; Micielli RL; DePestel DD; Arndt J; Strachan CL; Welch KB; Chenoweth CE
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):201-6. PubMed ID: 21460503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical factors associated with development of severe-complicated Clostridium difficile infection.
    Shivashankar R; Khanna S; Kammer PP; Harmsen WS; Zinsmeister AR; Baddour LM; Pardi DS
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1466-71. PubMed ID: 23702192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis.
    Navaneethan U; Mukewar S; Venkatesh PG; Lopez R; Shen B
    J Crohns Colitis; 2012 Apr; 6(3):330-6. PubMed ID: 22405170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors associated with Clostridium difficile infection in kidney transplant recipients.
    Spinner ML; Stephany BR; Cerrato PM; Lam SW; Neuner EA; Patel KS
    Transpl Infect Dis; 2018 Aug; 20(4):e12918. PubMed ID: 29797632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
    Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
    Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses.
    Anderson DJ; Rojas LF; Watson S; Knelson LP; Pruitt S; Lewis SS; Moehring RW; Sickbert Bennett EE; Weber DJ; Chen LF; Sexton DJ;
    PLoS One; 2017; 12(5):e0176285. PubMed ID: 28510584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of serious complications due to Clostridium difficile infection.
    Gujja D; Friedenberg FK
    Aliment Pharmacol Ther; 2009 Mar; 29(6):635-42. PubMed ID: 19077106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prediction of complicated Clostridium difficile infections in children.
    Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):901-3. PubMed ID: 24915226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.